Surgery Partners (SGRY) Q4 Earnings Report Preview: What To Look For

As Surgery Partners Inc. (SGRY) prepares to release its fourth quarter 2024 earnings report on March 3, 2025, investors are eager to understand the key performance indicators (KPIs) and trends that will shape the company's future. With a market capitalization of over $10 billion, Surgery Partners is a leading healthcare services company that specializes in short-stay surgical facilities. The company's Q4 earnings report will provide valuable insights into its financial health, operational performance, and growth prospects.



Revenue Growth and Earnings per Share (EPS)
One of the primary KPIs investors will be focusing on is Surgery Partners' revenue growth and earnings per share (EPS). In the fourth quarter of 2024, the company is expected to report revenue of $828.10 million and EPS of $0.22 per share. These estimates reflect a 9.3% revenue growth rate and an 83.6% earnings growth rate compared to the same period in 2023. Investors will be looking for any deviations from these estimates and the underlying reasons behind them.

Adjusted EBITDA Margin
Another crucial KPI is Surgery Partners' adjusted EBITDA margin, which measures the company's operating efficiency and profitability. In the fourth quarter of 2024, the company is expected to report an adjusted EBITDA margin of 19.4%. Investors will be analyzing this metric to assess the company's ability to control costs and maintain profitability in the face of potential headwinds.

Same-Facility Revenue Growth
Same-facility revenue growth is a critical KPI that measures the increase in revenue generated by existing facilities. This metric helps investors understand the organic growth of the business and the underlying demand for Surgery Partners' services. In the fourth quarter of 2024, the company is expected to report same-facility revenue growth of 8.1% compared to the same period in 2023.

Cash Flow from Operations (CFO)
Cash flow from operations (CFO) is a vital KPI that reflects the company's ability to generate cash from its core operations. Investors will be analyzing Surgery Partners' CFO to assess the company's financial health and its ability to fund growth initiatives and pay down debt. In the fourth quarter of 2024, the company is expected to report CFO of $18.5 million.

Debt-to-EBITDA Ratio
The debt-to-EBITDA ratio is a crucial KPI that measures the company's leverage and its ability to service its debt obligations. Investors will be analyzing Surgery Partners' debt-to-EBITDA ratio to assess the company's financial health and its ability to manage its debt burden. In the fourth quarter of 2024, the company is expected to report a debt-to-EBITDA ratio of 3.5x.

In conclusion, investors should focus on Surgery Partners' (SGRY) revenue growth, earnings per share (EPS), adjusted EBITDA margin, same-facility revenue growth, cash flow from operations (CFO), and debt-to-EBITDA ratio when analyzing the company's Q4 2024 earnings report. These KPIs will provide valuable insights into the company's financial health, operational performance, and growth prospects. As the company continues to expand its footprint and adapt to the evolving healthcare landscape, investors can expect Surgery Partners to maintain its position as a leading provider of short-stay surgical services.